1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Adult
Subject:  Aged
Date Issued:  [2010 TO 2016]

Results 1-6 of 6 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
16-Oct-2014Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor.Johnson, Douglas B; Flaherty, Keith T; Weber, Jeffrey S; Infante, Jeffrey R; Kim, Kevin B; Kefford, Richard F; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan S ; Sharfman, William H; McWilliams, Robert R; Sznol, Mario; Lawrence, Donald P; Gibney, Geoffrey T; Burris, Howard A; Falchook, Gerald S; Algazi, Alain; Lewis, Karl; Long, Georgina V; Patel, Kiran; Ibrahim, Nageatte; Sun, Peng; Little, Shonda; Cunningham, Elizabeth; Sosman, Jeffrey A; Daud, Adil; Gonzalez, Rene
21-Apr-2014A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.Lau, David K ; Andrews, Miles C; Turner, Natalie; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
323-Jul-2013The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S 
427-Feb-2013Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan S ; Itoh, Kyogo; Chen, Weisan
523-Jun-2011Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S 
64-Nov-2010Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.Svobodová, Suzanne; Browning, Judy; MacGregor, Duncan; Pollara, Gabriele; Scolyer, Richard A; Murali, Rajmohan; Thompson, John F; Deb, Siddhartha; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S